Table 5.
Investigational agents for MDS patients after hypomethylating therapy failure
N indicates number of patients; ORR, overall response rate; BID, 2 times/d; PO, per os; and NR, not reported.
Investigational agents for MDS patients after hypomethylating therapy failure
N indicates number of patients; ORR, overall response rate; BID, 2 times/d; PO, per os; and NR, not reported.
